Tandem Diabetes Care, Inc. (TNDM) fair value analysis
Nasdaq · Updated 2026-09-07
Tandem Diabetes Care, Inc. manufactures and sells insulin pump systems and related products designed to help people with diabetes manage their condition. The company operates globally, serving patients in multiple countries through its diabetes care technology and support services.
Valuation status
Awaiting full valuationTNDM does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under our standards — we require at least six validated trailing price-to-earnings windows before publishing one. TickrTrends re-evaluates every covered stock weekly; a verdict publishes automatically once enough validated history accumulates.
- Last price
- $20.11
- Sector
- Healthcare
- 12-month range
- $12.41–$25.23
Derived indicators
Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.
- Quality grade
- D
- Leverage
- High
- RSI zone
- Neutral
- 50/200-day trend
- Mixed
- 52-week position
- The upper-middle quarter of its range
What our data shows for TNDM
- Shares are trading in the middle of their 12-month price range of $12.41–$25.23.
- The 14-day relative strength index sits at a neutral 47.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for TNDM
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.
Recent TNDM news
TickrTrends' derived news-sentiment signal for TNDM is currently leaning positive, computed from recent coverage.
- A Look at Tandem Diabetes Care Inc (TNDM) After 3.4% Decline -- GF Value $24.05 vs Price $20.56 (gurufocus.com, 2026-09-03)
TickrTrends take: Tandem Diabetes Care operates in the Healthcare sector where consistent valuation metrics are crucial for investors tracking fundamental value. The recent price movement has created a gap between the GF Value estimate and the current market price that warrants monitoring as additional financial data becomes available. TickrTrends' awaiting full valuation status suggests that investors should track upcoming earnings reports or analyst updates before drawing conclusions about whether current levels represent opportunity or risk. - Tandem Diabetes Care, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:TNDM) 2026-08-07 (seekingalpha.com, 2026-08-07)
TickrTrends take: Tandem Diabetes Care released its second quarter 2026 results, providing updated operational and financial metrics for investors tracking the company's performance in the healthcare sector. With TickrTrends currently awaiting full valuation data for TNDM, the earnings presentation offers key figures on revenue, profitability, and guidance that will be essential for establishing a comprehensive valuation assessment. Valuation-focused readers should examine the company's cash flow generation, margin trends, and any updates to market growth expectations within the diabetes management device market that could inform fair value estimates. - Tandem Diabetes Care, Inc. (TNDM) Q2 2026 Earnings Call Transcript (seekingalpha.com, 2026-08-07)
TickrTrends take: Tandem Diabetes Care's Q2 2026 earnings call provides an opportunity for investors to assess whether the company's financial performance justifies its current valuation, which TickrTrends has marked as awaiting full assessment. As a healthcare company in the competitive diabetes care market, TNDM's revenue growth, profitability trends, and product adoption rates disclosed during the earnings discussion will be critical inputs for establishing a comprehensive valuation framework. Valuation-focused observers should monitor management's guidance on market expansion and competitive positioning to understand whether the company's fundamentals align with pricing expectations in the sector.
What people are saying
Follow the TNDM conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is TNDM stock undervalued?
TNDM does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under TickrTrends' standards; it is re-evaluated every week.
What is TNDM's TickrTrends verdict?
TNDM is currently marked 'Awaiting full valuation' - a verdict publishes automatically once at least six validated trailing P/E windows accumulate.
Is TNDM overbought or oversold?
TNDM's 14-day RSI is in neutral territory - neither overbought nor oversold.